In vitro injury model for oligodendrocytes: Development, injury, and recovery
β Scribed by Araceli Espinosa De Los Monteros; Paul M. Zhao; Jean De Vellis
- Book ID
- 102888482
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 923 KB
- Volume
- 52
- Category
- Article
- ISSN
- 1059-910X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
In this study we investigated the effects of severe hypothermia (cryoinjury) on oligodendrocyte (OL) cell marker expression and morphological features. We used a chemically defined cell culture medium, glial development medium (GDM), which favored the optimal expression of the OL phenotype in CG4 cells. Experiments using CG4 cells cultured in 2% serum or in GDM were conducted in parallel. After severe hypothermia, cells were reanimated at 37Β°C and 4.5% CO~2~ and cultured in either GDM or in medium supplemented with 2% serum. In either medium, around 70% of the total number of cells detached within 2 to 4 hours following reanimation. Oligodendroglial markers such as A2B5, O4, Tf, ferritin, tubulin, and MBP were examined by double and triple immunofluorescence. All of these markers except MBP reβappeared at different times during the recovery period for up to 48 hours. Glial fibrillary acidic protein (GFAP) and heat shock protein 60 (HSPβ60) were used as injury markers. The presence of serum induced HSPβ60 expression, while GDM did not. All CG4 cells expressed HSPβ60 in response to hypothermia independently of the cell culture medium used. Cryoinjury induced a spectrum of morphological changes in CG4 cells. The expression of OL specific markers was also influenced by hypothermia. Moreover both, serum and cryoinjury induced the expression of HSPβ60 that colocalized with OL and myelin markers. The expression of GFAP by injured cells but not by normal cells corroborated the state of injury of CG4 cells. Microsc. Res. Tech. 52:719β730, 2001. Β© 2001 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract Stem cell transplantation is a promising approach for the treatment of traumatic brain injury, although the therapeutic benefits are limited by a high degree of donor cell death. Tissue engineering is a strategy to improve donor cell survival by providing structural and adhesive support